Clinical Trial Update: Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating two dosing regimens of olokizumab versus placebo in rheumatoid arthritis patients on methotrexate with active disease; trial completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Olokizumab (olokizumab)

Snippet

Sponsor: R-Pharm International, LLC | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2020-10-30